Balancing incentives for innovation with the need for affordable medicines relies on mechanisms that preserve patent protection while opening doors to affordable options when needed. Compulsory licensing is a policy tool that allows a government to authorize a third party to produce a patented medicine without the patent holder’s consent, usually with negotiated royalties paid to the patent owner. This approach leverages international flexibilities designed to protect public health, ensuring that access to essential medicines is possible during shortages or health emergencies while maintaining the overall incentive structure for research and development through market-based compensation. It directly improves access by enabling affordable, locally produced generics without permanently erasing IP rights. In contrast, extending patent terms or data exclusivity lengthens monopolies and raises prices, further delaying generic competition, which is why they’re not suitable for balancing IP incentives with access.

The shift described is driven by technology becoming the central force shaping industry, economy, and daily life. The Industrial Age refers to the era of steam power and mechanization in the 18th–19th centuries, so it’s not about the current transition. The Information Era and the Digital Age highlight the rise of information processing and digital tools, but the term that best captures the broad transformation across many technologies—from computing and networking to automation and beyond—is the Technological Age. This name emphasizes that technology as a whole, in its many forms, is redefining how we produce, communicate, and innovate in the 21st century, which aligns with the description of a rapid shift to information technology.

Technology is the practical use of scientific knowledge to design and create tools, systems, and methods that people use in everyday life. It can be a tangible product, like a smartphone or a medical implant, and it can be a process, such as how electricity is generated, how data is transmitted, or how crops are grown more efficiently. This dual nature—producing items and shaping the ways we make and use them—directly affects the quality of life by improving health, communication, mobility, safety, and convenience. Science, on the other hand, is about understanding how things work rather than applying that knowledge to build tools. The prehistoric period is a time frame, and society refers to people and their relationships, not the act of applying knowledge to create things. So the best fit is technology.

Science communication in disaster risk reduction is about translating scientific understandings of hazards into clear, practical guidance people can act on. It involves conveying what the risks are, what can be done to prepare, and which resilience measures will help communities recover, all in a way that is credible and accessible. When messages are clear, timely, and tailored to diverse audiences, they help people understand the threat level, know exactly what actions to take (such as evacuation plans, emergency kits, or shelter procedures), and maintain trust in the information source. This trusted, actionable communication leads to appropriate responses and reduces panic, ultimately strengthening overall resilience. It isn’t limited to technical details for experts, nor is it about avoiding risk or relying only on government warnings; it integrates risk information with practical steps and community needs so people can protect themselves and help others.